Day 1 - January 10keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Day 1 - January 10 - PST/PDT (Pacific Daylight, GMT-7)
keyboard_arrow_leftSearch & Filter
search
Streams
Formats
Day 1 - January 10 - PST/PDT (Pacific Daylight, GMT-7)
search
Streams
Formats
All times are in PST
Day 1 - January 10 06:30 - 07:3060 mins
Networking
BiotechBikers Virtual Zwift and Peloton Ride and Networking
Day 1 - January 10 08:00 - 09:0060 mins
Biotech Showcase 1
Outsmarting Cancer: Next Generation Therapies
- Kevin DeGeeter - Managing Director, Healthcare Research, Oppenheimer & Co. Inc.
- William Ho - CEO, In8bio
- Kanya Rajangam - CMO, Nkarta Therapeutics
- Spiro Rombotis - President and CEO, Cyclacel Pharmaceuticals
- Weimin Tang - CBO, I-Mab Biopharma
- Lihua Zheng - CBO and Co-Founder, AnHeart Therapeutics
Day 1 - January 10 08:00 - 09:0060 mins
Biotech Showcase 2
Psychedelics: Once Stigmatized, Are Now the Newest Therapeutics on the Block for Mental Health
- Walter Greenleaf - Distinguished Visiting Scholar, Stanford University’s MediaX Program
- Bob Dougherty - VP, Digital Health Research, COMPASS Pathways
- Doug Drysdale - CEO, Cybin
- Adam Gazzaley - David Dolby Distinguished Professor of Neurology, Physiology & Psychiatry, UC San Francisco
- Berra Yazar-Klosinski - CSO, Multidisciplinary Association for Psychedelic Studies (MAPS)
On Demand
Company Presentations
Company presentations will be held On-Demand for viewing in the partneringONE system.
Day 1 - January 10 08:00 - 08:2020 mins
Additional Programming: Cell and Gene Therapies State of the Industry Briefing
ARM Cell and Gene State of the Industry Briefing: Introduction & Industry Update
- Janet Lambert - CEO, Alliance for Regenerative Medicine
- Emile Nuwaysir - CEO, Ensoma; Chairman, Alliance for Regenerative Medicine (ARM); Chairman, CEO, BlueRock Therapeutics
Day 1 - January 10 08:20 - 09:0545 mins
Additional Programming: Cell and Gene Therapies State of the Industry Briefing
2022: A Banner Year for Rare Genetic Disease Therapies?
- Bob Smith - SVP, Global Gene Therapy Business, Pfizer Inc.
- Harold Bernstein - Chief Medical Officer and SVP, BioMarin
- Jason Cole - CBO, bluebird bio
- Bobby Gaspar - CEO, Orchard Therapeutics
- Suma Krishnan - Founder and COO, Krystal Biotech
Day 1 - January 10 09:00 - 10:0060 mins
Biotech Showcase 1
The Decision to Launch on your Own: Critical Success Factors
- Todd Matthews - Senior Director, Corporate Alliances, IQVIA
- Christoph Broja - Principal, Gurnet Point Capital
- Susan Kitlas - VP, Precommercial Segment Lead, IQVIA
- Francesco Lavino - CEO, F2G
Day 1 - January 10 09:05 - 09:5045 mins
Additional Programming: Cell and Gene Therapies State of the Industry Briefing
Next Generation Therapies to Fight Cancer
- Robert Ang - CEO, Vor Biopharma
- Osvaldo Flores - CEO, Century Therapeutics
- Steven Kelly - President and CEO, CARISMA Therapeutics
- Alison Moore - Chief Technical Officer, Allogene Therapeutics
Day 1 - January 10 10:30 - 11:0030 mins
Biotech Showcase 1
Royalty Licenses: An Economic Asset Often Ignored
- Tom Burns - Senior VP, Finance and CFO, XOMA
- James R. Neal - CEO and Member, Board of Directors, XOMA
- Juliane Snowden - Founder, The Oratorium Group
Day 1 - January 10 12:00 - 13:0060 mins
Biotech Showcase 1
Beyond the COVID-19 Crisis: What We Learned in Record Time and How it Will Advance the Future
- Jeremy Abbate - Publisher, Scientific American
- Mara Aspinall - Managing Director, Health Catalysts Group
- Rick Bright - CEO, Pandemic Prevention Institute & Senior VP, Pandemic Prevention & Response, Health Initiative, The Rockefeller Foundation
- Michael Brooks - Chief Development Officer and Global Head, Clinical Development Solutions, Syneos Health
- Michelle McMurry-Heath - President and CEO, Biotechnology Innovation Organization (BIO)
Day 1 - January 10 14:45 - 15:4560 mins
Digital Medicine and Medtech Showcase
Investment Trends in Digital Medicine
- Katya Hancock - Investment Network Director, StartUp Health
- David J. Kim - Managing Director, DigiTx Partners
- Dennis J. Purcell - Founder and Senior Advisor, Aisling Capital
- Liz Rockett - Managing Director, Kaiser Permanente Ventures
Day 1 - January 10 16:00 - 17:0060 mins
Biotech Showcase 1
Investing for Commercial Success as an Emerging Company
- Naveen Murthy - Senior Managing Director, Head of Product & Franchise Strategy, Commercial Advisory Group, Consulting, Syneos Health
- Sachin Purwar - Director of Commercial Advisory Group, Consulting, Syneos Health
- Michael Sarshad - Director of Commercial Advisory Group, Consulting, Syneos Health
Day 1 - January 10 16:30 - 17:3060 mins
Biotech Showcase 2
Pharma Perspective: A Post-Pandemic Time of Transformation
- Bryan Katz - Senior VP and Global Head, Solution Development, Syneos Health
- Phyllis Barkman Ferrell - Global Head, External Engagement, Alzheimer’s disease and Neurodegeneration, Eli Lilly & Company
- Chihiro Hosoya - Head of Venture Management and Business Development, Astellas Rx+ Business Accelerator
- Philippe Lopes-Fernandes - Executive VP and CBO, Ipsen
- John McDonald - Corporate VP, Global R&D Business Development, Novo Nordisk
Filter
Streams
Formats